Android Apple

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?

By Yahoo! Finance   |   5 months ago
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Are Analysts Optimistic?

Rigel Pharmaceuticals, Inc. is a biotech company focusing on therapies for hematologic disorders and cancer. Analysts predict the company will break even in 2024, with profitability expected in 2025.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.